[Clinical pharmacology of fominoben].
D000284:Administration, Oral; D000328:Adult; D000813:Anilides / Q000494:pharmacology / Q000627:therapeutic use; D000996:Antitussive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D001784:Blood Gas Analysis; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D050260:Carbohydrate Metabolism; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D004569:Electroencephalography; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008744:Methylamines / Q000494:pharmacology / Q000627:therapeutic use; D009025:Morpholines / Q000494:pharmacology* / Q000627:therapeutic use; D010100:Oxygen / Q000097:blood; D010313:Partial Pressure; D010919:Placebos; D011651:Pulmonary Artery; D012119:Respiration / Q000187:drug effects
D000813:Anilides; D000996:Antitussive Agents; D001786:Blood Glucose; D008744:Methylamines; D009025:Morpholines; D010919:Placebos; D010100:Oxygen
Klinische Pharmakologie von Fominoben.